Trial Profile
The effect of antihypertensives, amlodipine and telmisartan, on serum visfatin and insulin resistance in patients with essential hypertension with and without insulin resistance.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Dec 2011
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Telmisartan (Primary)
- Indications Essential hypertension
- Focus Pharmacodynamics
- 28 Dec 2011 New trial record